Multicenter phase II study of a combination of cyclosporine a, methotrexate and mycophenolate mofetil for GVHD prophylaxis: results of the Chinese Bone Marrow Transplant Cooperative Group (CBMTCG).
about
How do we choose the best donor for T-cell-replete, HLA-haploidentical transplantation?Haploidentical hematopoietic transplantation without T-cell depletion: current status and future perspectivesDesialylation is associated with apoptosis and phagocytosis of platelets in patients with prolonged isolated thrombocytopenia after allo-HSCT.Donor-specific anti-human leukocyte antigen antibodies were associated with primary graft failure after unmanipulated haploidentical blood and marrow transplantation: a prospective study with randomly assigned training and validation setsFavorable outcome of haploidentical hematopoietic stem cell transplantation in Philadelphia chromosome-positive acute lymphoblastic leukemia: a multicenter study in Southwest ChinaUnrelated cord blood transplantation for adult patients with acute myeloid leukemia: higher incidence of acute graft-versus-host disease and lower survival in male patients transplanted with female unrelated cord blood--a report from Eurocord, the AAllogeneic stem cell transplantation for X-linked agammaglobulinemia using reduced intensity conditioning as a model of the reconstitution of humoral immunity.Azacytidine mitigates experimental sclerodermic chronic graft-versus-host disease.Plerixafor (a CXCR4 antagonist) following myeloablative allogeneic hematopoietic stem cell transplantation enhances hematopoietic recovery.Minimal residual disease- and graft-vs.-host disease-guided multiple consolidation chemotherapy and donor lymphocyte infusion prevent second acute leukemia relapse after allotransplant.Antifungal prophylaxis of patients undergoing allogenetic hematopoietic stem cell transplantation in China: a multicenter prospective observational study.Overview of the progress on haploidentical hematopoietic transplantation.Upfront haploidentical transplant for acquired severe aplastic anemia: registry-based comparison with matched related transplant.Prophylactic use of low-dose interleukin-2 and the clinical outcomes of hematopoietic stem cell transplantation: A randomized study.Similar incidence of severe acute GVHD and less severe chronic GVHD in PBSCT from unmanipulated, haploidentical donors compared with that from matched sibling donors for patients with haematological malignancies.Platelet transfusion refractoriness after T-cell-replete haploidentical transplantation is associated with inferior clinical outcomes.Notch pathway plays a novel and critical role in regulating responses of T and antigen-presenting cells in aGVHD.
P2860
Q26748867-B3438437-2822-40E3-8124-BE5AD3147611Q28080452-98937E98-7513-4DA3-A9B4-7DD5F4505332Q33427006-D1C82904-19D6-44B3-88FD-69DF44B36A93Q35834570-49494D0C-9268-45F3-B803-BE47513A9EE6Q35888941-0D1523BA-D4BC-44ED-8B4D-0FF427C4CCB4Q36125603-B4B3D0FC-7026-412F-A4A5-ABBAA54EAEEEQ36577708-F6ABE5BC-3CEA-4777-818A-0355ECC37909Q37064425-FDDBF041-BE8E-4B15-AAFB-54E3CFABC278Q37185324-A08C737F-1AD4-454F-A211-96F3C01046DCQ37258220-1020A370-BB5C-4251-B218-EED45A1F6C6CQ37280740-6F5EECF1-2DB9-4E1E-8DBB-4C797B0DDB21Q37522577-431BBB4E-87A1-4D09-82D0-4F9212C2540CQ37597265-25E4C424-E04D-4F86-8072-3BCF5A7421BCQ42968779-329EFAF2-195C-4625-B85D-150FA3B4B633Q47648662-FDDB1645-D312-4C81-A0F6-DAF051036B04Q50072576-B7CEAEDF-51EF-4FDE-A980-01BDB680A531Q51369795-983E619D-6E36-4EBC-8EF3-D181A8063F98
P2860
Multicenter phase II study of a combination of cyclosporine a, methotrexate and mycophenolate mofetil for GVHD prophylaxis: results of the Chinese Bone Marrow Transplant Cooperative Group (CBMTCG).
description
2014 nî lūn-bûn
@nan
2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Multicenter phase II study of ...... nt Cooperative Group (CBMTCG).
@ast
Multicenter phase II study of ...... nt Cooperative Group (CBMTCG).
@en
Multicenter phase II study of ...... nt Cooperative Group (CBMTCG).
@nl
type
label
Multicenter phase II study of ...... nt Cooperative Group (CBMTCG).
@ast
Multicenter phase II study of ...... nt Cooperative Group (CBMTCG).
@en
Multicenter phase II study of ...... nt Cooperative Group (CBMTCG).
@nl
prefLabel
Multicenter phase II study of ...... nt Cooperative Group (CBMTCG).
@ast
Multicenter phase II study of ...... nt Cooperative Group (CBMTCG).
@en
Multicenter phase II study of ...... nt Cooperative Group (CBMTCG).
@nl
P2093
P2860
P1476
Multicenter phase II study of ...... nt Cooperative Group (CBMTCG).
@en
P2093
Deng-Ming Hu
Kai-Yan Liu
Ming Jiang
Paul Schwarzenberger
Qiao-Chuan Li
Yong-Rong Lai
Yu-Hong Chen
P2860
P2888
P356
10.1186/S13045-014-0059-3
P577
2014-08-21T00:00:00Z
P5875
P6179
1015313430